Corticosteroids for chronic obstructive pulmonary disease (inhaled, ICS): ~11% ↓ in exacerbations & slows ↓ FEV1; no Δ in mortality (Lancet 2016;387:1817). Greatest benefit if eos >300 (Lancet Repir Med 2018;6:117).